Huatai Pharma Inc. – FDA Inspection, Mar 24, 2023

Record Details

This FDA Inspection record concerns Huatai Pharma Inc., with an inspection on March 24, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Huatai Pharma Inc.
Inspection Date: March 24, 2023
Product Type: Drugs
Office: Center for Drug Evaluation and Research
Person: Tonia F. Bernard

View Company Profile

ID · 67e7868b-4433-4b6d-9562-80e3e1c9ccd5

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1202319
FDA center: Human Drugs
Project area: Drug Quality Assurance
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Huatai Pharma Inc.

FDA Inspection

Huatai Pharma Inc.March 24, 2023